Regular gabapentin use appeared to increase risk of dementia by 29% and mild cognitive impairment by 85%, researchers reported n the journal Regional Anesthesia & Pain Medicine. Photo by ...
The anti-seizure drug gabapentin is used to treat epilepsy, nerve pain after shingles and restless legs syndrome by affecting chemical messengers in the brain and nerves. Common side effects include ...
Gabapentin, which is also used as an anti-seizure medication, has a low risk of addiction, so it's generally considered much safer than opioids for treating chronic pain. However, a new study points ...
Health and Me on MSN
Gabapentin, A Common Drug For Nerve Pain, Just Got An NHS Warning—Here’s Why
Gabapentin, one of the most commonly prescribed painkillers in the UK, has come under renewed attention after an NHS alert ...
Comparison of Pharmacokinetics and Pharmacodynamics of Docetaxel and Cisplatin in Elderly and Non-Elderly Patients: Why Is Toxicity Increased in Elderly Patients? One hundred twenty-one consecutive ...
Women who carry a particular form of a pain gene are more likely to respond well to a common medication used to treat long-term discomfort, research shows. In a study, women with chronic pelvic pain ...
Gabapentin does not decrease pain before and after patients undergo primary total knee arthroplasty, according to a study reported in Anesthesiology News. The study showed no significant difference ...
Gabapentin is a medication that some people take to treat epilepsy, restless legs syndrome, or nerve pain from shingles. It also goes by the brand names Neurontin, Gralise, and Horizant. Gabapentin ...
A compound -- one of 27 million screened in a library of potential new drugs -- reversed four types of chronic pain in animal studies, according to new research. The small molecule, which binds to an ...
If your dog suffers from seizures or chronic pain, your veterinarian may have prescribed a medication called gabapentin. Originally approved by the FDA as anti-seizure medication for humans, ...
The India Gabapentin Market offers opportunities driven by rising neurological disorders, especially among diabetic and aging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results